Brain Cancer (Treatment)

Adoptive Immunotherapy Slowed Some Tumor Growth

Published in Vaccine Weekly, July 27th, 1998

A new treatment that activates a person's immune system appears to lead to remission in some patients with a common form of aggressive brain cancer, according to a Cleveland Clinic, Cleveland, Ohio, study published in the July 1998 issue of the Journal of Neurosurgery.

In the study, 10 patients with recurrent malignant gliomas were treated by adoptive immunotherapy, an intravenous infusion of their own activated immune cells. Three patients had reduction in tumor size lasting at least six months. The patients also demonstrated a survival advantage. The typical length of survival following a recurrence of malignant gliomas is five months, while the median survival...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (1998-07-27)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry